Association of the estrogen receptor α gene polymorphisms with osteoporosis in the Mexican population

Clinical Genetics

Volumn 72, Issue 6, 2007, Pages 574-581

  Gomez A B ^a,b   Magana J J ^a,b   Cisneros, B ^b   Perez Salazar E ^b   Faugeron, S ^c   Veliz D ^d   Castro, C ^e   Rubio, J ^e   Casas, L ^a   Valdés Flores, Margarita ^a,f  

^a National Institute of Rehabilitation   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^d UNIVERSITY OF CHILE   (Chile)

^e UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^f NONE   (Mexico)

Author keywords

Bone mineral density; Dinucleotide polymorphism; Estrogen receptor alpha gene; Osteoporosis; Single nucleotide polymorphism

Indexed keywords

ADENINE; ESTROGEN RECEPTOR ALPHA; GUANINE; THYMIDINE;

ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; CONTROLLED STUDY; DINUCLEOTIDE REPEAT; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MARKER; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; LUMBAR SPINE; MAJOR CLINICAL STUDY; MEXICO; OSTEOPOROSIS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; BONE DENSITY; CASE-CONTROL STUDIES; DINUCLEOTIDE REPEATS; DNA PRIMERS; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MEXICO; OSTEOPOROSIS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 36248940799     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2007.00898.x     Document Type: Article

References (55)

1. Anonymous. Consensus development conference: Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993: 94 (6): 646-650.
2. Melton LJ III. Epidemiology worldwide. Endocrinol Metab Clin North Am 2003: 32 (1): 1-13.
3. Flicker L, Hopper JL, Rodgers L, Kaymakci B, Green RM, Wark JD. Bone density determinants in elderly women: A twin study. J Bone Miner Res 1995: 10 (11): 1607-1613.
4. Stewart TL, Ralston SH. Role of genetic factors in the pathogenesis of osteoporosis. J Endocrinol 2000: 166 (2): 235-245.
5. Slemenda CW, Christian JC, Williams CJ, Norton JA, Johnston CC. Genetic determinants of bone mass in adult women: A reevaluation of the twin model and the potential importance of gene interaction on heritability estimates. J Bone Miner Res 1991: 6 (6): 561-567.
6. Morrison NA, Qi JC, Tokita A et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994: 367 (6460): 284-287.
7. Magaña JJ, Gómez R, Cisneros B et al. Association of the CT gene (CA) polymorphism with BMD in osteoporotic Mexican women. Clin Genet 2006: 70 (5): 402-408.
8. Kobayashi S, Inoue S, Hosoi T, Ouchi Y, Shiraki M, Orimo H. Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res 1996: 11 (3): 306-311.
9. Ogawa S, Hosoi T, Shiraki M et al. Association of estrogen receptor beta gene polymorphism with bone mineral density. Biochem Biophys Res Commun 2000: 269 (2): 537-541.
10. Shiraki M, Shiraki Y, Aoki C et al. Association of bone mineral density with apolipoprotein E phenotype. J Bone Miner Res 1997: 12 (9): 1438-1445.
11. Langdahl BL, Knudsen JY, Jensen HK, Gregersen N, Eriksen EF. A sequence variation: 713-8delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women. Bone 1997: 20 (3): 289-294.
12. Hosoi T, Miyao M, Inoue S et al. Association study of parathyroid hormone gene polymorphism and bone mineral density in Japanese postmenopausal women. Calcif Tissue Int 1999: 64 (3): 205-208.
13. Murray RE, McGuigan F, Grant SF, Reid DM, Ralston SH. Polymorphisms of the interleukin-6 gene are associated with bone mineral density. Bone 1997: 21 (1): 89-92.
14. Grant SF, Reid DM, Blake G, Herd R, Fogelman I, Ralston SH. Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene. Nat Genet 1996: 14 (2): 203-205.
15. Zajickova K, Zofkova I. Osteoporosis: Genetic analysis of multifactorial disease. Endocr Regul 2003: 37 (1): 31-44.
16. Riggs BL, Melton LJ III. Involutional osteoporosis. N Engl J Med 1986: 314 (26): 1676-1686.
17. Lindsay R, Hart DM, Aitken JM, MacDonald EB, Anderson JB, Clarke AC. Long-term prevention of postmenopausal osteoporosis by oestrogen. Lancet 1976: 1 (7968): 1038-1041.
18. Ettinger B, Genant HK, Cann CE. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med 1985: 102 (3): 319-324.
19. Felson DT, Zhang Y, Hannan MT, Kiel DP, Wilson PW, Anderson JJ. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 1993: 329 (16): 1141-1146.
20. Korach KS. Insights from the study of animals lacking functional estrogen receptor. Science 1994: 266 (5190): 1524-1527.
21. Morishima A, Grumbach MM, Simpson ER, Fischer C, Quin K. Aromatase deficiency in male and female siblings caused by a novel mutation and a physiological role of estrogens. J Clin Endocrinol Metab 1995: 80 (12): 3689-3698.
22. Heng HH, Squire J, Tsui LC. High-resolution mapping of mammalian genes by in situ hybridization to free chromatin. Proc Natl Acad Sci U S A 1992: 89 (20): 9509-9513.
23. Smith EP, Boyd J, Frank GR et al. Estrogen resistance caused by mutation in the estrogen-receptor gene in a man. N Engl J Med 1995: 331 (16): 1088-1089.
24. Coleman RT, Taylor JE, Shine JJ, Frossard PM. Human estrogen receptor (ESR) gene locus: PssI dimorphism. Nucleic Acids Res 1988: 16 (14B): 7208.
25. Garcia T, Sanchez M, Cox JL et al. Identification of a variant form of the human estrogen receptor with an amino acid replacement. Nucleic Acids Res 1989: 17 (20): 8364.
26. Del Senno L, Aguiari GL, Piva R. Dinucleotide repeat polymorphism in the human estrogen receptor (ESR) gene. Hum Mol Genet 1992: 1 (5): 354.
27. Schubert EL, Lee MK, Newman B, King MC. Single nucleotide polymorphisms (SNPs) in the estrogen receptor gene and breast cancer susceptibility. J Steroid Biochem Mol Biol 1999: 71 (1-2): 21-27.
28. Gennari L, Merlotti D, De Paola V et al. Estrogen receptor gene polymorphisms and genetic osteoporosis: A HuGE review. Am J Epidemiol 2005: 161 (4): 307-320.
29. Sano M, Inoue S, Hosoi T et al. Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis. Biochem Biophys Res Commun 1995: 217 (1): 378-383.
30. Ongphiphandhanakul B, Chanprasertyothin S, Payyatikul P et al. Association of a G2014A transition in exon 8 of the estrogen receptor-alpha gene with postmenopausal osteoporosis. Osteoporos Int 2001: 12 (12): 1015-1019.
31. Aguirre BG. La poblacion negra de México. Secretaría de la Reforma Agrarias, Estudio Etnohistórico Mexico, Centro de Estudios del Agrarismo en México, Mexico: 1981.
32. Stavenhagen R, Carrasco T. La diversidad étnica y cultural. In: Florescano E, El patrimonio Nacional de México. 1st edn. Mexico, D.F.: Consejo Nacional para la Cultura y las Artes, 1997: 249-280.
33. Pritchard JK, Stephens M, Rosenberg NA, Donelly P. Association mapping in structured populations. Am J Hum Genet 2000: 67 (1): 170-181.
34. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: A laboratory manual. New York: Cold Spring Harbor Laboratory Press, 1989.
35. Tsukamoto K, Emi M. A polymorphic CA repeat sequence at the human calcitonin locus. J Hum Genet 1998: 43 (2): 146-147.
36. Pritchard JK, Rosenberg NA. Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet 1999: 65 (1): 220-228.
37. Rousset F, Raymond M. Testing heterozygote excess and deficiency. Genetics 1995: 140 (4): 1413-1419.
38. Wigginton JE, Cutler DJ, Abecacis GR. A note on exact test of Hardy-Weinberg equilibrium. Am J Hum Genet 2005: 76 (5): 887-893.
39. Parra EJ, Marcini A, Akey J et al. Estimating African American admixture proportions by use of population-specific alleles. Am J Hum Genet 1998: 63 (6): 1839-1851.
40. Martinez-Marignac VL, Valladares A, Cameron E et al. Admixture in Mexico City: Implications for admixture mapping of type 2 diabetes genetic risk factors. Hum Genet 2007: 120 (6): 807-819.
41. Ewens WJ, Spielman RS. The transmission/disequilibrium test: History, subdivision, and admixture. Am J Hum Genet 1995: 57 (2): 455-464.
42. Tang H, Quertermous T, Rodriguez B et al. Genetic structure, self-identified race/ethnicity, and confounding in case-control association studies. Am J Hum Genet 2005: 76 (2): 268-275.
43. Clayton DG, Walker NM, Smyth DJ et al. Population structure, differential bias and genomic control in large-scale, case-control association study. Nat Genet 2005: 37 (11): 1243-1246.
44. Becherini L, Gennari L, Massi L et al. Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women. Hum Mol Genet 2000: 9 (13): 2043-2050.
45. van Meurs JB, Schuit SC, Weel AE et al. Association of 5′-estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk. Hum Mol Genet 2003: 12 (14): 1745-1754.
46. Langdahl BL, Lokke E, Carstens M, Stenkjaer LL, Eriksen EF. A TA repeat polymorphism in the estrogen receptor gene is associated with osteoporotic fractures but polymorphisms in the first exon and intron are not. J Bone Miner Res 2000: 15 (11): 2222-2230.
47. Sowers M, Willing M, Burns T et al. Genetic markers, bone mineral density, and serum osteocalcin levels. J Bone Miner Res 1999: 14 (8): 1411-1419.
48. Willing MC, Torner JC, Burns TL et al. Gene polymorphisms, bone mineral density and bone mineral content in young children: The Iowa Bone Development Study. Osteoporos Int 2003: 14 (8): 650-658.
49. Chen HY, Chen WC, Tsai HD, Hsu CD, Tsai FJ, Tsai CH. Relation of the estrogen receptor alpha gene microsatellite polymorphism to bone mineral density and the susceptibility to osteoporosis in post-menopausal Chinese women in Taiwan. Maturitas 2001: 40 (2): 143-150.
50. Yim CH, Choi JT, Choi HA et al. Association of estrogen receptor alpha gene microsatellite polymorphism with annual changes in bone mineral density in Korean women with hormone replacement therapy. J Bone Miner Metab 2005: 23 (5): 395-400.
51. Albagha OM, McGuigan FE, Red DM, Ralston SH. Estrogen receptor α gene polymorphism and bone mineral density: Haplotype analysis in women from the UK. J Bone Miner Res 2001: 16 (1): 128-134.
52. Kenealy MR, Flouriot G, Sonntag-Buck V, Dandekar T, Brand H, Gannon F. The 3′-untraslated region of the human estrogen receptor alpha gene mediates rapid messenger ribonucleic acid turnover. Endocrinology 2000: 141 (8): 2805-2813.
53. Keaveney M, Parker MG, Gannon F. Identification of a functional role for the 3′ region of the human oestrogen receptor gene. J Mol Endocrinol 1993: 10 (2): 143-152.
54. Xia J, Scherer SW, Cohen PT et al. A common variant in PPP1R3 associated with insulin resistance and type 2 diabetes. Diabetes 1998: 47 (9): 1519-1524.
55. Ringe JD, Dorst AJ. Osteoporosis in men pathogenesis and clinical classification of 254 cases. Dtsch Med Wochenschr 1994: 119 (27): 943-947.